Literature DB >> 17416103

A brief history of tau: the evolving view of the microtubule-associated protein tau in neurodegenerative diseases.

G L Lace1, S B Wharton, P G Ince.   

Abstract

The major historical milestones in tau-research are reviewed, with their implications for changing perspectives about the significance of tau-pathology in neurodegeneration. Abnormalities of tau-protein characterize the pathology of numerous neurodegenerative disorders, both sporadic and inherited. Over the years, opinions regarding the significance of tau in disease pathogenesis, particularly in Alzheimer's disease, have fluctuated. Early caution about the role of tau as a significant factor in neurodegenerative disease, especially Alzheimer's disease, has been superseded by acceptance of its key involvement in pathways which led to cell dysfunction and death. The discovery of familial "tauopathies", associated with tau-gene mutations, has confirmed that tau-dysmetabolism can independently lead to neurodegeneration. Debate about the centrality of its role remains, but current evidence makes it difficult to ignore the importance of tau in many neurodegenerative diseases. By examining the evolution of research on tau, related to advances in technology and the emergence of new diseases, the future developments needed to resolve remaining issues in the tau-story may be discerned.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17416103     DOI: 10.5414/npp26043

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN: 0722-5091            Impact factor:   1.368


  13 in total

1.  Hyperdynamic microtubules, cognitive deficits, and pathology are improved in tau transgenic mice with low doses of the microtubule-stabilizing agent BMS-241027.

Authors:  Donna M Barten; Patrizia Fanara; Cathy Andorfer; Nina Hoque; P Y Anne Wong; Kristofor H Husted; Gregory W Cadelina; Lynn B Decarr; Ling Yang; Victoria Liu; Chancy Fessler; Joan Protassio; Timothy Riff; Holly Turner; Christopher G Janus; Sethu Sankaranarayanan; Craig Polson; Jere E Meredith; Gemma Gray; Amanda Hanna; Richard E Olson; Soong-Hoon Kim; Gregory D Vite; Francis Y Lee; Charles F Albright
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

2.  Active and passive immunization strategies based on the SDPM1 peptide demonstrate pre-clinical efficacy in the APPswePSEN1dE9 mouse model for Alzheimer's disease.

Authors:  Marybeth Camboni; Chiou-Miin Wang; Carlos Miranda; Jung Hae Yoon; Rui Xu; Deborah Zygmunt; Brian K Kaspar; Paul T Martin
Journal:  Neurobiol Dis       Date:  2013-09-08       Impact factor: 5.996

Review 3.  Therapeutic strategies for Alzheimer's disease.

Authors:  Donna M Barten; Charles F Albright
Journal:  Mol Neurobiol       Date:  2008-06-26       Impact factor: 5.590

4.  Tuning microtubule-based transport through filamentous MAPs: the problem of dynein.

Authors:  Michael Vershinin; Jing Xu; David S Razafsky; Stephen J King; Steven P Gross
Journal:  Traffic       Date:  2008-03-28       Impact factor: 6.215

Review 5.  Review: Contact sport-related chronic traumatic encephalopathy in the elderly: clinical expression and structural substrates.

Authors:  A Costanza; K Weber; S Gandy; C Bouras; P R Hof; P Giannakopoulos; A Canuto
Journal:  Neuropathol Appl Neurobiol       Date:  2011-10       Impact factor: 8.090

6.  Cardiovascular dementia - a different perspective.

Authors:  Udhaya Kumari; Klaus Heese
Journal:  Open Biochem J       Date:  2010-03-26

7.  Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology.

Authors:  Katharina Stratmann; Helmut Heinsen; Horst-Werner Korf; Domenico Del Turco; Estifanos Ghebremedhin; Kay Seidel; Mohamed Bouzrou; Lea T Grinberg; Jürgen Bohl; Stephen B Wharton; Wilfred den Dunnen; Udo Rüb
Journal:  Brain Pathol       Date:  2015-08-24       Impact factor: 6.508

8.  High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation.

Authors:  David O Azorsa; RiLee H Robeson; Danielle Frost; Bessie Meec hoovet; Gillian R Brautigam; Chad Dickey; Christian Beaudry; Gargi D Basu; David R Holz; Joseph A Hernandez; Kristen M Bisanz; Leslie Gwinn; Andrew Grover; Joseph Rogers; Eric M Reiman; Michael Hutton; Dietrich A Stephan; Spyro Mousses; Travis Dunckley
Journal:  BMC Genomics       Date:  2010-01-12       Impact factor: 3.969

9.  The actin-binding protein capulet genetically interacts with the microtubule motor kinesin to maintain neuronal dendrite homeostasis.

Authors:  Paul M B Medina; Ryan J Worthen; Lawrence J Forsberg; Jay E Brenman
Journal:  PLoS One       Date:  2008-08-25       Impact factor: 3.240

Review 10.  Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease.

Authors:  Francesco Panza; Vincenzo Solfrizzi; Davide Seripa; Bruno P Imbimbo; Madia Lozupone; Andrea Santamato; Chiara Zecca; Maria Rosaria Barulli; Antonello Bellomo; Alberto Pilotto; Antonio Daniele; Antonio Greco; Giancarlo Logroscino
Journal:  Biomed Res Int       Date:  2016-06-26       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.